Login to Your Account

Something Old and Something New

Multiple Myeloma Sequencing IDs Usual Suspects, New Foes

By Anette Breindl

Thursday, March 24, 2011
Researchers reported that they have sequenced multiple genomes of multiple myeloma tumors. The resulting genomic landscape has turned up well-known foes – but also new and unexpected ones, including mutations in BRAF, the target of Plexxikon Inc.'s melanoma drug hopeful PLX4032.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription